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Abstract
Salmonella as a causative agent in septic bursitis 
is considered rare. We report a case of 56 year 
old male with history of renal transplantation and 
using mycophenolate mofetil, cyclosporine and 
methylprednisolone as maintenance,  admitted due to 
3-week-fever associated with tenderness and swelling 
on left shoulder. Upon investigation, a diagnosis of septic 
bursitis was established. Salmonella enteritidis as the 
definitive causative agent was revealed. He was treated 
with meropenem 1g IV three times daily and levofloxacin 
500 mg IV once a day for 3 weeks, followed by oral 
ciprofloxacin 500 mg twice a day for 2 weeks and oral 
metronidazole 500 mg three times a day for 1 week 
with a total duration of 5 weeks of antibiotics. On the 
subsequent follow up there was no recurrence episode 
of fever and the swelling of the left shoulder subsided, 
no tenderness noted and the patient has no limitation 
of range of movement. Since immunocompromised 
state complicates the management, the duration of 
therapy may twice longer than the typical management 
of septic bursitis. Salmonella as etiologic agent should 
be considered as differential in immunocompromised 
patient with septic bursitis.
Keywords: Immunocompromised state, septic bursitis, 
deep bursae, Salmonella, duration of therapy.
Introduction
Bursa is an enclosed sac which contains a small 
amount of synovial fluid, lined with a cellular 
membrane similar to synovium.1-3,7 Bursae may be 
divided based on its  location into superficial and 
deep. Septic bursitis on deep bursae may occurred 
in patients with bacteremia and more common in 
the immunocompromised state.2-8,16,20 The patient is 
in immunosuppressive therapy on mycophenolate 
mofetil and cyclosporine secondary to post renal 
transplantation.
Septic bursitis refers to inflammation of the 
bursa which  is due to infection, typically resulting 
from bacterial inoculation either direct (e.g, 
puncture wound), spread from nearby soft tissues 
(e.g, cellulitis), or hematogenous (e.g, bacterial 
endocarditis). Much less commonly, mycobacteria, 
fungi, or algae are the causative agents.
The most common cause of septic bursitis 
both in immunocompetent or immuncompromised 
population mentioned in some references is 
Staphylococcus aureus (>80%) followed by 
Streptococcus.2,6,12,16 Salmonella as an etiologic 
agent in septic bursitis is rare and reported in less 
than 1% as an infectious cause in bone and joint 
infection.20  In this case report, we present a case of 
septic bursitis in immunocompromised patient with 
Salmonella enteritidis as the causative agent.
Case Report
A 56 year old male with a history of renal 
transplantation on mycophenolate mofetil 
(2x250 mg), cyclosporine (2x25 mg), and 
methylprednisolone (2 mg, q48h) maintenance, 
presented with a chief complaint of fever associated 
with left shoulder tenderness 3 weeks prior to 
admission. Initially, he got on and off fever for 1 
week with more frequent at night. He  medicated 
himself with over the counter medicine, no consult 
was done. Three weeks prior to admission, he began 
complaining of left shoulder stiffness and swelling. 
He sought consult to a physician, upon ultrasound 
examination revealed fluid accumulation on his left 
shoulder. Fluid aspiration was taken, on culture 
result shown Salmonella spp. He was later referred 
to Cipto Mangunkusumo General Hospital for 
further evaluation and management.
On physical examination, upon admission he 
had a temperature of 38,5 0C and other vital signs 
were normal. The patient was able to walk, but he 
has an obvious pain and fatigue. His left shoulder 
was swollen and fluctuation, limited of range of 
movement, no wound puncture or sign of skin 
infections either on the left shoulder or other parts 
of the body. The rest of physical examination was 
unremarkable.
Upon admission, accumulation of fluid on 
subacromion subdeltoid bursa was found by 
ultrasound, fluid aspiration was yellow and cloudy 
fluid (Figure 1). Fluid analysis shown 208440 cells/
µl with 94% neutrophils (Table 1 and Table 2). A 
culture of the bursa aspirate reveals Salmonella 
enteritidis. Then the patient was given meropenem 
1g IV q8h and levofloxacin 500 mg IV once a 
day for three weeks. Mycophenolate mofetil and 
cyclosporine was continued.
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Table 1. Laboratory examination result
Parameters Result Reference
Hb 9.1 g/dL 13−16	g/dL
Ht 26.5% 40−48%
MCV 71 fL 82−92	fL
MCH 24.4 pg 27−31	pg
WBC 4.85x103 /µL 5−10	x	103 /µL
Platelets 129000 150000−400000
Diff count
Eosinophil 1.4% 1−3%
Neutrophil 48.3% 52−76%
Lymphocyte 37.9% 20−40%
Monocyte 12.2% 2−8%
Ureum 47 mg/dL <50 mg/dL
Creatinine 1.00 mg/dL 0.8−1.3	mg/dL
eGFR 83.8 mL/min/1.73 m2 79−117	mL/min/1,73	m2
Na 148 mEq/L 132−147	mEq/L
K 3.8 mEq/L 3.3−5.4	mEq/L
Procalcitonin 1.07 ng/mL <0.05 ng/mL
Hb: Hemoglobin; Ht: Hematocrite; MCV: Mean Corpuscular Volume; 
MCH: Mean Corpuscular Hemoglobin; WBC: White Blood Cells; eGFR: 
Estimated Glomerular Filtration Rate; Na: Sodium; K: Potassium
Table 2. Bursal fluid analysis
Test Reference Result
Macroscopic
Color Colorless Brown
Clarity Clear Cloudy
Viscosity <4 cm
Mucin clot test Negative Poor
Microscopic
Cell count 208440/µL
Diff. count
PMN (segment) 196680 (94%)/µL
MN (lymphocyte) 11760.0 (0.05%)/µL
Crystals No uric crystals found
Fluid Protein 8.0
Fluid Glucose 80
Fluid uric acid 6
Serum uric acid 3.5−7.2 4.0
Rheumatoid Factor <11
PMN: Polymorphonuclear cells; MN: Mononuclear cells
During hospitalization, no recurrence episode of fever and 
swelling of the left shoulder improvement observed. MRI 
(Magnetic Resonance Imaging) on left shoulder shown 
abscess formation with M. supraspinatus, tendon of M. biceps 
brachii and left subacromial bursa involvement. After 3 weeks 
of hospitalization, ultrasound follow up revealed no fluid 
accumulation in subacromial subdeltoid bursa. Antibiotics 
shifted to oral ciprofloxacin 500 mg twice a day for 2 weeks 
and metronidazole 500 mg thrice a day for 1 week, hence 
discharged (Figure 2). Three weeks after discharged, upon 
follow up there was no recurrence episode of fever and the 
swelling of the left shoulder subsided, no tenderness noted and 
the patient has no limitation of range of movement.
Figure 1. Ultrasound of the left shoulder, prior aspiration (left) 
and on aspiration (right)
Figure 2. MRI of the left shoulder 
Figure 3. Photos taken after 3 weeks of antibiotic course. 
The left shoulder swelling subsided.
Discussion
Bursitis is an inflammation or degeneration of the sac-like 
structures which form in utero to protect the soft tissues 
from underlying bony prominences.9 Septic bursitis refers 
to inflammation of the bursa which  is cause infection. 
Septic bursitis on deep bursae may have been occurred in 
patients with bacteremia which is more common in the 
immunocompromised state. 2-8,16,20 Deep bursae includes 
subacromial, iliopsoas, trochanter bursa, direct inoculation 
to these structures are  rare although iatrogenic infections 
may occur through injection procedure to the bursa, intra 
articular injection, acupuncture.16,17 If no direct inoculation 
or iatrogenic course found, hematogenic seeding must be 
considered and impaired response to infection is one of the 
predisposing factor.16 In our report, the patient is taking 
immunosuppressive agent (i.e mycophenolate mofetil, 
cyclosporine and methylprednisolone). 
The definitive pathogen in this case is Salmonella 
enteritidis inoculated from the infected bursa. Salmonella is 
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considered rare as a causative agent in both septic bursitis 
and septic arthritis.4,5,18,20 Sky et al, in his report mentioned 
the Salmonella as etiologic agent in bone and joint infection 
in <1% of cases.20 The peak incidence of nonthyphoidal 
salmonellosis (NTS) is on rainy season in tropical climates, and 
during the warmer months in temperate climates, coinciding 
with the peak in foodborne outbreaks.18 The mortality and 
morbidity is significant in immunocompromised populations. 
Transmission is most commonly associated with animal food 
products, especially egg, poultry, undercooked ground meat, 
dairy products, and fresh produce contaminated with animal 
waste.18 More than 8% of this infection causes bacteremia.13
Diagnostic approach in septic bursitis includes history and 
physical examination. Ultrasound, CT scan, MRI, is helpful 
in defining bursal effusion within deep bursae. Bursal fluid 
aspiration is indicated if effusions and septic bursitis are present 
or suspicious. Laboratory analysis of bursal fluid consists of 
determination of the nucleated cell count (white cell count), 
Gram stain, and culture for bacteria.7,16 Immunocompromised 
hosts may have  more limited inflammatory response. A 
threshold for bursal leukocytosis of >2000/mm3 [>2.0 x 109/L] 
was noted to have a sensitivity and specificity for septic bursitis 
of 94 % and 79 %, respectively, in a study of 36 patients with 
olecranon or prepatellar bursitis. The sensitivity of gram 
stain ranges from 15 − 100 %. Bursal fluid glucose utility is 
uncertain, the majority of patients with septic bursitis have a 
low glucose level defined as serum glucose ratio <50%.16
Overall managements of septic bursitis consists of 
antibiotic therapy, drainage, and surgical intervention.14 In 
our case, we administered antibiotic therapy and drainage. 
What differs of management in immunocompetent and 
immunocompromised host is the duration of antibiotic 
therapy. The immunosuppressive agents taken by the patient 
complicates the management. Antibiotic therapy duration in 
septic bursitis is dictated by the clinical response, microbiologic 
findings, and general conditions of the host. In general, 
antibiotic therapy is given in 2−3 weeks duration and more 
prolonged between 4 and 6 weeks in more serious infection 
in compromised host or even three times longer.2,14-16,19 
Hirsansuthikul et al, 2016 reported antibiotic duration for 5 
weeks in management of septic bursitis  in HIV patients.3 Olut 
et al, 2012 in his case report giving antibiotics for 8 weeks in 
managing septic arthritis of hip caused S.Typhi in a multiple 
sclerosis patient who was under steroid therapy.5 Both of the 
reports give an excellent follow up with no significant residual 
lesion.3,5 In our report, we administered meropenem 3x1g IV, 
levofloxacin 1x500 mg IV as guided by the culture results 
for 3 weeks, followed by oral ciprofloxacin 2x500 mg for 2 
weeks and oral metronidazol 3x500 mg for 1 week with a total 
duration of 5 weeks. On subsequent follow up, the patient 
reported no recurrence of fever, improvement in left shoulder 
tenderness and range of movement, the swelling is subsided.
Conclusion
Septic bursitis is referred as a condition of infection in 
bursa which may occur from direct inoculation, iatrogenic 
cause from joint aspiration, or hematogenic seeding from 
bacteremia. Septic bursitis on deep bursae may have been 
occurred in patients with bacteremia  which is more common 
in the immunocompromised state. Salmonella is considered 
rare as a causative agent in both septic bursitis and septic 
arthritis, more than 8% of this infection causes bacteremia. 
Bursal fluid analysis and culture may confirm the diagnosis. 
Immunocompromised state complicates the management of 
septic bursitis, hence the duration of therapy may twice longer 
than the typical duration in the immunocompetent host.
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